SecBot SecBot

Facilitating Innovative Nuclear Diagnostics Act of 2023

S. 1544 Sen. Marsha Blackburn (R-TN) In committee
Bill text PDF
  1. Introduced May 10
  2. Committee May 10
  3. Passed Senate Next
  4. Passed House Not yet
  5. To President Not yet
  6. Law Not yet
Where it stands
In committee, May 10, 2023Next: Senate vote
1267d ago May 10, 2023: Read twice and referred to the Committee on Finance.
Final votes
No roll callsNo recorded vote on this bill yet
Lobbying
2companies, 2 filings
Subscribe to see spend
Member trades
0trades in the last 90 days
None in these companies
Who backs the bill and who pushes back Subscribe

Companies lobbying on this bill

2 companies
Companies by sector
Biotech & Pharma 1Other 1
Search all 2 companies, their asks and price moves Subscribe

Summary

Facilitating Innovative Nuclear Diagnostics Act of 2023

Full summary1 paragraphs

This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2024 and as adjusted based on a specified fee schedule factor in each year thereafter.

Library of Congress summary, May 10, 2023

Summary versions
  • Introduced in SenateMay 10, 2023

Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.